Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - fexofenadine hydrochloride 120mg - film coated tablet - 120 mg - active: fexofenadine hydrochloride 120mg excipient: colloidal silicon dioxide croscarmellose sodium isopropyl alcohol magnesium stearate maize starch mannitol opadry pink 03b54504 powdered cellulose purified water - relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older. label claim: for the relief of symptoms of hay fever allergies: itchy and runny nose, itchy and watery eyes, sneezing, itchy throat.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - fexofenadine hydrochloride 180mg - film coated tablet - 180 mg - active: fexofenadine hydrochloride 180mg excipient: colloidal silicon dioxide croscarmellose sodium isopropyl alcohol magnesium stearate maize starch mannitol opadry pink 03b54504 powdered cellulose purified water - relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older. label claim: for the relief of symptoms of hay fever allergies: itchy and runny nose, itchy and watery eyes, sneezing, itchy throat. itchy skin rash/hives (urticarial): swelling related to allergy, swelling related to hives, itchy skin rash, itch caused by hives.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - pseudoephedrine hydrochloride, quantity: 120 mg; fexofenadine hydrochloride, quantity: 60 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; pregelatinised maize starch; carnauba wax; colloidal anhydrous silica; stearic acid; macrogol 8000; hypromellose; macrogol 400 - for the relief of the symptoms of seasonal allergic rhinitis with nasal congestion when both the antiallergic properties of fexofenadine hydrochloride and the decongestant activity of pseudoephedrine hydrochloride are required.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - fexofenadine hydrochloride 6 mg/ml; fexofenadine hydrochloride 6 mg/ml - oral suspension - 6 mg/ml - active: fexofenadine hydrochloride 6 mg/ml excipient: butyl hydroxybenzoate dibasic sodium phosphate heptahydrate disodium edetate monobasic sodium phosphate monohydrate poloxamer propyl hydroxybenzoate propylene glycol purified water raspberry flavour f-9950 pfc sucrose titanium dioxide xanthan gum xylitol active: fexofenadine hydrochloride 6 mg/ml excipient: dibasic sodium phosphate heptahydrate disodium edetate monobasic sodium phosphate monohydrate poloxamer potassium sorbate propylene glycol purified water raspberry flavour f-9950 pfc sucrose titanium dioxide xanthan gum xylitol - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 6 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; butyl hydroxybenzoate; propyl hydroxybenzoate; titanium dioxide; disodium edetate; purified water; monobasic sodium phosphate monohydrate; poloxamer; xylitol; propylene glycol; dibasic sodium phosphate heptahydrate; sucrose; flavour - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age. relief of symptoms associated with urticaria in adults and children from 6 months of age.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 30 mg - tablet, film coated - excipient ingredients: titanium dioxide; pregelatinised maize starch; hypromellose; macrogol 400; colloidal anhydrous silica; magnesium stearate; povidone; microcrystalline cellulose; croscarmellose sodium; iron oxide red; iron oxide yellow - relief of symptoms associated with seasonal allergic rhinitis, allergic rhinitis or urticaria in adults and children from 6 years of age.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

physicians total care, inc. - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precau

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

state of florida doh central pharmacy - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings and precautions.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precautions.) ketoconazole is contrain

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

rebel distributors corp - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precautions section

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

stat rx usa llc - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warnings, warnings and precautions sections.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precautions se